198 related articles for article (PubMed ID: 29742245)
21. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
[TBL] [Abstract][Full Text] [Related]
22. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia.
Pérez-López J; Selva-O'Callaghan A; Grau-Junyent JM; Gallego-Galindo L; Coll MJ; García-Morillo S; Torralba-Cabeza MA; Vilardell-Tarrés M
Mol Genet Metab; 2015 Apr; 114(4):580-3. PubMed ID: 25752415
[TBL] [Abstract][Full Text] [Related]
23. Newborn screening for Pompe disease in Japan.
Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
[TBL] [Abstract][Full Text] [Related]
24. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J
Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480
[TBL] [Abstract][Full Text] [Related]
25. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
[TBL] [Abstract][Full Text] [Related]
26. The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease.
Bevilacqua JA; Guecaimburu Ehuletche MDR; Perna A; Dubrovsky A; Franca MC; Vargas S; Hegde M; Claeys KG; Straub V; Daba N; Faria R; Periquet M; Sparks S; Thibault N; Araujo R
Orphanet J Rare Dis; 2020 Jan; 15(1):11. PubMed ID: 31931849
[TBL] [Abstract][Full Text] [Related]
27. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
[TBL] [Abstract][Full Text] [Related]
28. Reevaluating the pathogenicity of the mutation c.1194 +5 G>A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy.
Amiñoso C; Gordillo-Marañón M; Hernández J; Solera J
Neuromuscul Disord; 2019 Mar; 29(3):187-191. PubMed ID: 30770309
[TBL] [Abstract][Full Text] [Related]
29. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
[TBL] [Abstract][Full Text] [Related]
30. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity.
Wierzba-Bobrowicz T; Lewandowska E; Lugowska A; Rola R; Stepień T; Ryglewicz D; Pasennik E
Folia Neuropathol; 2007; 45(4):179-86. PubMed ID: 18176891
[TBL] [Abstract][Full Text] [Related]
31. Screening for Pompe disease in a Portuguese high risk population.
Almeida V; Conceição I; Fineza I; Coelho T; Silveira F; Santos M; Valverde A; Geraldo A; Maré R; Aguiar TC; Mendonça C; Martins J; Medeiros L; Barroso C; Vieira JP; Moreno T; Negrão L; Dias MS; Lacerda L; Evangelista T
Neuromuscul Disord; 2017 Aug; 27(8):777-781. PubMed ID: 28554557
[TBL] [Abstract][Full Text] [Related]
32. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.
Lin N; Huang J; Violante S; Orsini JJ; Caggana M; Hughes EE; Stevens C; DiAntonio L; Chieh Liao H; Hong X; Ghomashchi F; Babu Kumar A; Zhou H; Kornreich R; Wasserstein M; Gelb MH; Yu C
Clin Chem; 2017 Apr; 63(4):842-851. PubMed ID: 28196920
[TBL] [Abstract][Full Text] [Related]
33. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
[TBL] [Abstract][Full Text] [Related]
34. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
[TBL] [Abstract][Full Text] [Related]
35. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.
Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA
Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766
[TBL] [Abstract][Full Text] [Related]
36. Homozygotic intronic GAA mutation in three siblings with late-onset Pompe's disease.
Grzesiuk AK; Shinjo SM; da Silva R; Machado M; Galera MF; Marie SK
Arq Neuropsiquiatr; 2010 Apr; 68(2):194-7. PubMed ID: 20464284
[TBL] [Abstract][Full Text] [Related]
37. Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations.
Oba-Shinjo SM; da Silva R; Andrade FG; Palmer RE; Pomponio RJ; Ciociola KM; S Carvalho M; Gutierrez PS; Porta G; Marrone CD; Munoz V; Grzesiuk AK; Llerena JC; Berditchevsky CR; Sobreira C; Horovitz D; Hatem TP; Frota ER; Pecchini R; Kouyoumdjian JA; Werneck L; Amado VM; Camelo JS; Mattaliano RJ; Marie SK
J Neurol; 2009 Nov; 256(11):1881-90. PubMed ID: 19588081
[TBL] [Abstract][Full Text] [Related]
38. Toward deconstructing the phenotype of late-onset Pompe disease.
Schüller A; Wenninger S; Strigl-Pill N; Schoser B
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
[TBL] [Abstract][Full Text] [Related]
39. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing lysosomal storage disorders: Pompe disease.
Bodamer OA; Dajnoki A
Curr Protoc Hum Genet; 2012 Oct; Chapter 17():Unit17.11. PubMed ID: 23074069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
